Cancer patients are resorting to fetching lifesaving medicines from China, which has become a biotech powerhouse.

Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.

Editor's note: This story has been updated to reflect that Stanford Medicine is now providing daraxonrasib via expanded access in advance of FDA approval. It’s not often that a new pancreatic cancer ...

An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new ...

There is no shortage of advice on what to eat after one receives a diagnosis of cancer. The possibility that dietary interventions could enhance cancer treatment outcomes has generated considerable ...

Advances in early screening mammography and new, targeted treatments have reduced overall mortality and recurrence in breast cancer. Yet, despite these advances in traditional treatment options, some ...

Researchers at the Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University have discovered that tiny structural defects can trigger the breakdown of microtubules, the microscopic structures ...

UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer, the school ...

Cancer remains one of the leading causes of death worldwide, yet recent studies suggest there may be a simple tool to help lower risk and improve outcomes: physical activity. In a recent study ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A diagnosis of cancer often leaves people searching for ways to resume control of their bodies and minds. Food is one of the first places they turn, and one message looms large in our information ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...